A disciplined, highly targeted approach to discovering new cancer medicines
Rigorous, definitive clinical trials based on deep biology and chemistry expertise
Committed to bringing differentiated new cancer medicines to patients
ARIAD's first internally discovered and developed medicine
ARIAD and STA Announce Approval of Iclusig (Ponatinib) in Australia
ARIAD Announces Iclusig Data Presentations at Annual American Society of Hematology Meeting
A shared commitment to patients and each other. This is ARIAD.
click here for PDF